Coronavirus company news summary – Parsons partners on testing technology – Portsmouth Naval Shipyard 3D prints swabs

19 May 2020 (Last Updated May 19th, 2020 09:11)

19 May

Defence technology company Parsons and non-profit research and development organisation Fraunhofer USA have partnered to develop a digital Covid-19 detector. The companies will focus on a diamond electrode biosensor. The prototype will be used for direct and quick detection of the virus. A prototype is anticipated to be ready for initial testing and development this summer. Parsons president and chief operating officer Carey Smith said: "As many parts of the world start the process of re-opening, testing capabilities are a critical component of a safe return to work, school and daily living."

Portsmouth Naval Shipyard (PNSY) and US Army Medical Materiel Development Activity (USAMMDA) have reached a memorandum of agreement (MoA) to produce 3-D Printed nasopharyngeal test swabs for Covid-19. The coffee stirrer sized swabs are made using surgical grade resin and feature bristled ends to collect a sample from the nasal cavity. Currently, PNSY has the capacity to manufacture up to 10,000 swabs per day. These swabs can be used by the US Department of Defense in conjunction with FDA EUA Covid-19 testing kits.

The US Army’s oldest medical unit 1st Medical Brigade has successfully implemented a new concept Urban Augmentation Medical Task Force (UAMTF) to combat Covid-19, reports Spc Samantha Hall. UAMTF is designed to allow the service to quickly deploy medical assets provided by the Army Reserve. The new unit includes self-sufficient medical personnel who are better prepared to cater to the specific needs of a mission or situation.